Abstract:Background: Hepatocellular carcinoma (HCC) is the second lethal malignancy among all cancers. Many molecular alterations have been found in HCC. However, the interactions and modulatory mechanisms among these molecules in HCC are still unclear. Methods: CTB-193M12.5 expression in tissues and cells were detected by quantitative polymerase chain reaction (qPCR). In vitro experiments were conducted to evaluate the function of CTB-193M12.5 in cell proliferation, apoptosis, migration and invasion. The interaction between CTB-193M12.5 and nuclear receptor binding SET domain-containing protein 1 (NSD1) was assessed by RNA??? protein pull-down and RNA immunoprecipitation assays. The roles of CTB-193M12.5 on WNT10B and Wnt/??-catenin signaling was detected by chromatin immunoprecipitation assay, qPCR, Western blot, and dual luciferase reporter assay. Results: We identified a novel prognosis-related long noncoding RNA (lncRNA) CTB-193M12.5 in HCC. CTB-193M12.5 was upregulated in HCC and its high expression was correlated with alpha fetoprotein, large tumor size, aggressive clinical characteristics, and poor survival. Functional experiments showed that CTB-193M12.5 enhanced HCC cellular proliferation, suppressed HCC cellular apoptosis, and promoted HCC cellular migration and invasion. CTB-193M12.5 knockdown exerted opposite effects in HCC. Mechanistic investigation demonstrated that CTB-193M12.5 was mainly distributed in nucleus. Histone methyltransferase NSD1 was identified as a CTB-193M12.5 interactor. CTB-193M12.5 bound and recruited NSD1 to the promoter of WNT10B, leading to an increase in di-methylation of histone H3 at lysine 36 (H3K36me2) and the reduction of tri-methylation of histone H3 at lysine 27 (H3K27me3) at WNT10B promoter. Therefore, CTB-193M12.5 epigenetically activated WNT10B transcription. Through upregulating WNT10B, CTB-193M12.5 further activated Wnt/??-catenin signaling. Functional rescue experiments demonstrated that overexpression of WNT10B reversed the tumor suppressive roles of CTB-193M12.5 knockdown, while Wnt/??-catenin signaling inhibitor ICG-001 abolished the oncogenic roles of CTB-193M12.5 overexpression. Conclusion: CTB-193M12.5 was a highly expressed and poor prognosis-related lncRNA in HCC. CTB-193M12.5 functioned as an oncogenic lncRNA through promoting NSD1-mediated WNT10B/Wnt/??-catenin signaling activation.

LINC00665 Activates Wnt/β-catenin Signaling Pathway to Facilitate Tumor Progression of Colorectal Cancer Via Upregulating CTNNB1.

LINC00346 Promotes Pancreatic Cancer Progression Through the CTCF-mediated Myc Transcription

LINC00365 promotes colorectal cancer cell progression through the Wnt/β‐catenin signaling pathway

Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression

LINC00265 Promotes Colorectal Tumorigenesis Via ZMIZ2 and USP7-mediated Stabilization of Β-Catenin

Up-regulation of LINC00467 Promotes the Tumourigenesis in Colorectal Cancer.

To Wnt or Lose: the Missing Non-Coding Linc in Colorectal Cancer

LincROR Promotes Tumor Growth of Colorectal Cancer Through the Mir-145/Wnt2b/wnt10a/wnt/β-catenin Regulatory Axis

LINC02595 promotes tumor progression in colorectal cancer by inhibiting miR‐203b‐3p activity and facilitating BCL2L1 expression

Long noncoding RNA LINC01550 inhibits colorectal cancer malignancy by suppressing the Wnt/β-catenin signaling pathway

LncRNA AC010789.1 Promotes Colorectal Cancer Progression by Targeting MicroRNA-432-3p/ZEB1 Axis and the Wnt/β-Catenin Signaling Pathway

Long Noncoding RNA LINC00520 Accelerates the Progression of Colorectal Cancer by Serving As a Competing Endogenous RNA of Microrna-577 to Increase HSP27 Expression.

LINC00689 Promotes Prostate Cancer Progression Via Regulating Mir-496/Ctnnb1 to Activate Wnt Pathway

LINC00941 promotes CRC metastasis through preventing SMAD4 protein degradation and activating the TGF-β/SMAD2/3 signaling pathway

High LINC00536 Expression Promotes Tumor Progression and Poor Prognosis in Bladder Cancer

Upregulated LINC01088 Facilitates Malignant Phenotypes and Immune Escape of Colorectal Cancer by Regulating Micrornas/g3bp1/pd-L1 Axis

Long Non-coding RNA LINC00115 Contributes to the Progression of Colorectal Cancer by Targeting miR-489-3p via the PI3K/AKT/mTOR Pathway

LINC01123 Promotes Progression of Colorectal Cancer Via Mir-625-5p/lasp1 Axis

CTB-193M12.5 Promotes Hepatocellular Carcinoma Progression Via Enhancing NSD1-Mediated WNT10B/Wnt/β-Catenin Signaling Activation

Long Intergenic Noncoding RNA 00665 Promotes Proliferation and Inhibits Apoptosis in Colorectal Cancer by Regulating Mir-126-5p

Upregulated Expression of Long Non-Coding RNA, LINC00460, Suppresses Proliferation of Colorectal Cancer